-
US ambassador denounces settler siege as Israel dispatches troops
-
Taiwan chokes mobile internet speeds in drill for Chinese attack
-
Hasan takes 6-55 as Bangladesh claim opening day of Australia Test
-
From Chinese AI to Global ETFs: STARTRADER Launches 45 New 24/7 Stock and ETF CFDs
-
Taiwan says AI agents used in cyberattacks targeting island
-
Tech stocks enjoy rebound after US inflation on mixed day for markets
-
Japan protests Putin's first visit to disputed islands
-
Hasan takes 6-55 as Bangladesh bundle out Australia for 198
-
Kiss wants fit-again Wallabies playmaker Gordon to 'open up' Japan
-
Swiatek sinks Svitolina to set up Rybakina title clash in Toronto
-
British eccentrics push humble garden shed to new heights
-
Australia's Pallister shines, mixed relay record falls as Pan Pacs open
-
Zambia votes with president's economic record on the line
-
Hasan puts Bangladesh in charge as Australia struggle to 183-8
-
Germany's dry rivers spark battle on engineering vs restoration
-
Putin visits Kuril islands claimed by Japan
-
Senators demand inquiry into conditions aboard USS Abraham Lincoln
-
Swiatek downs Svitolina to reach first WTA final of 2026
-
All Blacks' Proctor out of South Africa series, Mo'unga called up
-
Jones says Japan 'watching videos of geese' for Australia clash
-
Bangladesh quick Hasan reduces Australia to 74-4 at lunch
-
Bloodied but unbowed, defending champ Shelton reaches Montreal final
-
Seoul tech leads Asian stock gains as traders cheer US inflation
-
Wallabies make eight changes for return Japan Test
-
Farage and Count Binface go head-to-head in snap UK poll
-
Messi returns after father's death but Miami knocked out of Leagues Cup
-
Afghan students divided over smartphone ban at universities
-
Outflanked by AI, stars fade for South Korea's blind fortune-tellers
-
Japan go back to school for second Australia Test
-
Venezuela govt, opposition wrap up round of post-Maduro talks
-
Matthew McConaughey on his sweet return to the big screen
-
Five things to know about Zambia as it goes to the polls
-
President's economic record on the line as Zambia votes
-
Nakashima holds off Jodar to book first ATP Masters final in Montreal
-
Grieving Messi available for Miami in Leagues Cup clash
-
Trump 'low-key' bets on economic pressure against Iran
-
Colombia enters 'final phase' of quake search as toll hits 265
-
Pitch invaders take selfies with Fernandes during Man Utd friendly
-
Father-figure Christie helps guide Kounta to European silver
-
No-stress Sabalenka won't fret over lackluster 2026 results
-
McIlroy returns to St. Jude to launch marathon PGA playoff push
-
Hometown hero Hudson-Smith basks in Euro glory
-
Guimaraes makes Arsenal debut in Como friendly
-
PSG down Aston Villa to retain UEFA Super Cup
-
Travis Kelce says wedding to Taylor Swift was 'best night of my life'
-
Trump's spokesperson Karoline Leavitt to step down
-
US stocks mostly up after data shows slightly lower inflation in July
-
'Imposing ignorance': US climate science under siege
-
Caracas protest denounces secrecy of Venezuela transition talks
-
As millions gazed in awe, a swathe of Spain plunged into darkness
US overdose capital Baltimore on long road to recovery
Carrying a bag filled with the overdose-reversing drug naloxone, Adam Trionfo roams the brick-lined streets of one of America's oldest port cities, Baltimore.
The 40-year-old and his small team visit neighborhoods considered "hot spots" for drug trafficking to hand out the precious antidote, sold under the brand name Narcan.
The easy-to-use nasal spray has become a key tool in the fight against the deadly US opioid crisis, claiming 750,000 lives between the late 1990s and 2022.
"Just over the past week, we distributed 200 Narcan kits," Trionfo, who oversees an addiction assistance program with the local branch of Catholic Charities, told AFP.
On their route, the team spots a man sprawled out amid a pile of rubbish in the corner of a stairwell. They hand him a box of Narcan and a brochure about their organization.
The man takes it with one hand, as he awkwardly hides a syringe behind his back.
Their last Narcan kit goes to another man, legs covered in brown scars, who is waiting near a dilapidated building.
These scenes are not uncommon in this East Coast city, which is located about 50 kilometers (31 miles) from Washington and is renowned for endemic crime.
Baltimore was the setting of the hit television series "The Wire" in the early 2000s, depicting its burgeoning drug scene from a variety of angles.
And last year, the New York Times dubbed the city the "American overdose capital."
Between 2018 and 2022, the drug-related mortality rate was nearly twice as high as in any other major American city. The leading killer: fentanyl.
- 'Tremendous efforts' -
Since the height of the opioid crisis in 2021, the outlook has improved in much of the country, including in Baltimore.
The number of fatal overdoses in the city plummeted by 35 percent last year, to 680 down from 1,043 in 2023.
The city's proactive policies, coupled with preventative work done by Catholic charities in Baltimore's communities have helped make a dent in the problem.
"We've had tremendous efforts throughout the city to get people into treatment, and then we've also had tremendous efforts in getting Naloxone out there," said Michael Fingerhood, head of addiction medicine at Johns Hopkins Bayview Medical Center.
Distributed broadly for about a decade, Narcan has worked like a "fire extinguisher," Fingerhood said.
In Baltimore, Narcan is now available everywhere: pharmacies, vending machines throughout the city, even in libraries.
- Funded by restitution -
The drop in mortality in Baltimore is also linked to the composition of the fentanyl being sold there, Fingerhood said.
"The drug supply has less potent fentanyl and has additives that are less likely to cause overdose."
Awareness of the risks associated with the powerful synthetic opioid has also grown among users, pushing them to be more "cautious," said Bakari Atiba, community engagement director at Charm City Care Connection.
The nonprofit assists addicts in Baltimore -- known as Charm City -- and recently received funding from a restitution program fueled by lawsuits against opioid manufacturers and distributors.
"I'm not saying people are going to stop using," Atiba said. "That's not even our goal."
"It's about meeting people where they are, making sure they're safe, making sure they're supported, and making sure they have pathways to recovery if they want it."
H.Kuenzler--VB